Description

Health Canada has made changes to the policy on drug good manufacturing practices (GMP) and drug establishment licence (DEL) enforcement (POL-0004). This policy supports the consistent and transparent application of compliance and enforcement actions under Canada’s GMP and DEL regulatory schemes.

Resources

Name	Format	Description	Link
Changes to policy on drug good manufacturing practices and DEL enforcement (POL-0004)	HTML		https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/drug-establishment-licensing-bulletin/changes-policy-good-manufacturing-practices.html
Changes to policy on drug good manufacturing practices and DEL enforcement (POL-0004)	HTML		https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/conformite-application-loi/licences-etablissement/bulletin-licences-etablissement-pharmaceutiques/modifications-politique-bonnes-pratiques-fabrication.html

Tags

Topics

Categories